READ-OUTBlood-Based Biomarkers for Dementia Diagnosis in Diverse UK Memory Clinic Patients

Dementia is a growing concern in the UK, affecting more people and placing a burden on individuals and society. Accurate early diagnosis is crucial for timely intervention and care planning. The READ-OUT study focuses on testing blood-based biomarkers, which are indicators found in blood that can detect changes in the brain associated with dementia, particularly Alzheimer's disease. This research is important because it could offer a more accessible, less invasive, and cost-effective way to diagnose and predict dementia, compared to current methods that are not always available to all patients. Participants in the study, who come from diverse backgrounds and attend memory clinics across the UK, will provide a blood sample and answer questions about their quality of life and views on blood testing for dementia. The study will compare the accuracy of these blood tests against traditional diagnostic methods like clinical reviews and brain scans. Additionally, the study explores the reliability of repeated testing and the potential for patients to collect their own samples. The results aim to determine which blood tests are best for diagnosing dementia, their predictive ability, and their potential integration into the NHS, thus paving the way for better care and management of the disease.